MEF2D and hepatocellular carcinoma: The MEF2D signature was also higher in the transcriptome of intrahepatic metastases than that of the primary HCC lesions (Figure S1C, Supporting Information), indicating that MEF2D may be a potential integrator of pro‐metastatic niche signals.